CLASS II ONGOING Device recall · Reported 25 Jan 2023 · FDA Enforcement Report

MobiCT-32 AIRO Mobile CT Scanner recalled by Mobius Imaging

Mobius Imaging is recalling MobiCT-32 AIRO Mobile CT Scanner, distributed nationwide in the US. The recall was initiated on 7 Dec 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 00869346000200 ALL Serial numbers
Quantity recalled303

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0957-2023
FDA event ID
91258
Recalling firm
Mobius Imaging, Shirley, MA
Classification
Class II
Status
Ongoing
Recall initiated
7 Dec 2022
FDA classified
17 Jan 2023
Reported
25 Jan 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

7 Dec 2022Recall initiated by company
17 Jan 2023Classified by FDA+41 days
25 Jan 2023Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Stryker received one report of an injury to an untrained user that occurred while the untrained user was moving an Airo TruCT unit in reverse. The firm will increase visibility of instructions for users to consider when transporting the unit in reverse by providing labels to be affixed onto the AIRO.

Product as listed by the FDA

MobiCT-32 AIRO Mobile CT Scanner, Cat. No. MobiCT-32, mobile computed tomography system.

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Algeria, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Chinese Taipei, Denmark, Egypt, France, Germany, India, Italy, Japan, Kazakhstan, Korea, Republic of Kuwait, Lithuania, Malaysia, Mexico, Morocco, Nepal, Netherlands, Norway, Pakistan, Poland, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, United Arab Emirates, United Kingdom, Viet Nam.

Nationwide

Questions about this recall

Why was it recalled?

Stryker received one report of an injury to an untrained user that occurred while the untrained user was moving an Airo TruCT unit in reverse. The firm will increase visibility of instructions for users to consider when transporting the unit in reverse by providing labels to be affixed onto the AIRO.

Which lots are affected?

UDI-DI: 00869346000200 ALL Serial numbers

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Algeria, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Chinese Taipei, Denmark, Egypt, France, Germany, India, Italy, Japan, Kazakhstan, Korea, Republic of Kuwait, Lithuania, Malaysia, Mexico, Morocco, Nepal, Netherlands, Norway, Pakistan, Poland, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, United Arab Emirates, United Kingdom, Viet Nam.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Mobius Imaging

All 7

Other Imaging Equipment recalls

All 2,347